ADHD drug tested to help kids with rare speech disorder speak clearly
NCT ID NCT05185583
Summary
This small, completed study tested whether methylphenidate, a medication often used for ADHD, could improve speech clarity in children aged 6-12 with childhood apraxia of speech. Eighteen children participated in an 8-week trial where they took either the medication or a placebo for 4 weeks each, in a random order. The main goal was to see if the drug made their speech easier to understand compared to the dummy pill.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD APRAXIA OF SPEECH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
Conditions
Explore the condition pages connected to this study.